Cancer Immunotherapy. Progress in Molecular Biology and Translational Science Volume 164

Table of Contents

1. TNFR2 in cancer immunology and immunotherapy Xin Chen 2. From the Hellstrom paradox towards cancer cure Ingegerd Hellstrom and Karl Erik Hellstrom 3. CAR T-cell treatment of T-cell malignancy Martin Pule 4. Immunotherapy of pancreatic cancer Jorg Kleeff 5. Cancer stem cell immunology/immunotherapy Federica Cavallo 6. Cytokine release syndrome Alexander Shimabukuro-Vornhagen 7. Tumor Cell-Based Mechanisms of Resistance to Immune Attack Louis M. Weiner 8. Mushroom compounds in cancer immunotherapy Peter Amwoga Ayeka

Authors

David B. Teplow Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. Professor Teplow is a member of the Department of Neurology, David Geffen School of Medicine at UCLA; Director, UCLA Biopolymer Laboratory; and a member of the faculties of the Molecular Biology Institute, Brain Research Institute, Chemistry-Biology Interface Training Program, and various neuroscience graduate programs. Professor Teplow received degrees in Biochemistry, and in Bacteriology & Immunology, from UC Berkeley; a Ph.D. from the University of Washington, Seattle; and postdoctoral training at the California Institute of Technology, Pasadena, CA. From 1991-2005, Professor Teplow was a member of the faculty of the Department of Neurology, Harvard Medical School, Boston. Professor Teplow has published >200 peer-reviewed articles, including ~150 original articles and ~50 reviews, book chapters, and commentaries. Professor Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology. He currently is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease. Professor Teplow is a member of numerous national and international scientific advisory and editorial boards.